References
- Abulafia O, Pezzullo JC, Sherer DM (2003). Performance of ThinPrep liquid-based cervical cytology in comparison with conventionally prepared Papanicolaou smears: a quantitative survey. Gynecol Oncol, 90, 137-44. https://doi.org/10.1016/S0090-8258(03)00176-8
- Akyuz A, Guvenc G, Yavan T (2006). Evaluation of the Pap smear test status of women and of the factors affecting this status. Gulhane Med J, 48, 25-9.
- Almobarak AO, Elhoweris MH, Nour HM, et al (2013). Frequency and patterns of abnormal Pap smears in Sudanese women with infertility: What are the perspectives? J Cytol, 30, 100-3. https://doi.org/10.4103/0970-9371.112651
- Anttila A, Pukkala E, Soderman B, et al (1999). Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963-1995: recent increase in cervical cancer incidence. Int J Cancer, 83, 59-65. https://doi.org/10.1002/(SICI)1097-0215(19990924)83:1<59::AID-IJC12>3.0.CO;2-N
- Arbyn M, Bergeron C, Klinkhamer P, et al (2008). Liquid compared with conventional cervical cytology: a systema- tic review and meta-analysis. Obstet Gynecol, 111, 167-77. https://doi.org/10.1097/01.AOG.0000296488.85807.b3
- Atilgan R, Celik A, Boztosun A, et al (2012). Evaluation of cervical cytological abnormalities in Turkish population. Indian J Pathol Microbiol, 55, 52-5. https://doi.org/10.4103/0377-4929.94856
- Avwioro OG (2002) 1st ed. Claverianun press Nigeria; 2002. Histochemistry and Tissue Pathology.
- Baker JJ (2002). Conventional and liquid-based cervicovaginal cytology: a comparison study with clinical and histologic follow-up. Diagn Cytopathol, 27, 185-88. https://doi.org/10.1002/dc.10158
- Baris I, Karakaya YA (2013). Effects of Contraception on Cervical Cytology: Data from Mardin City. Turk Patoloji Derg, 29, 117-21.
- Bertolino J G, Rangel JE, Blake Jr. RL, Silverstein D, Ingram E (1992). Inflammation on the cervical Papanicolaou smear: the predictive value for infection in asymptomatic women. Family Medicine, 24, 447-52.
- Eser S, Yakut C, Ozdemir R, et al (2010). Canser incidence rates in Turkey in 2006: a detailed registry based estimation. Asian Pac J Cancer Prev, 11, 1731-9.
- Ferlay J, Shin HR, Bray F, et al (2008). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917.
- Gakidou E, Nordhagen S, Obermeyer Z (2008) Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities. Plos Med, 5.
- Gurel A.S, Gurel H, Topcuoglu A (2009). Investigation of rate and determinants of pap-test in women attending for a gynecological examination. Turkiye Klinikleri J Gynecol Obst, 19, 62-6.
- Juneja A, Sehgal A, Mitra AB, Pandey A (2003). A survey on risk factors with cervical cancer. Indian J Cancer, 40, 15-22.
- Karabulutlu O (2013). Evaluation of the pap smear test status of Turkish women and related factors. Asian Pac J Cancer Prev, 14, 981-6. https://doi.org/10.7314/APJCP.2013.14.2.981
- Karaca M (2008). How common is pap smear test known and performed. Turkiye Klinikleri J Gynecol Obst, 18, 22-8.
- Kulkarni PR, Rani H, Vimalambike M G, Ravishankar S (2013). Opportunistic screening for cervical cancer in a tertiary hospital in Karnataka, India. Asian Pac J Cancer Prev, 14, 5101-5. https://doi.org/10.7314/APJCP.2013.14.9.5101
- Michalas S P (2000). The Pap test: George N. Papanicolaou (1883- 1962). A screening test for the prevention of cancer of uterine cervix. European Journal of Obstetrics Gynecology and Repro- ductive Biology, 90, 135-8. https://doi.org/10.1016/S0301-2115(00)00260-8
- Ministry of Health (2008). Republic of Turkey Cancer Statistics, Available at: http://www.saglik.gov.tr/KSDB/BelgeGoster. aspx. (accessed 03.12.2013).
- Ministry of Health (2009). Ulusal kanser programi 2009-2015. Available at: http://www.saglik.gov.tr. (accessed 08.2013). In Turkey there were different results reported about the rate of the pap testing of women.
- Papanicolaou G. N (1942). A new procedure for staining vaginal smears. Science, 95, 438-9. https://doi.org/10.1126/science.95.2469.438
- Prompakay R, Promthet S, Kamsa-ard S, et al (2013). Relationship between the body mass index and abnormal pap smears. Asian Pac J Cancer Prev, 14, 5503-6. https://doi.org/10.7314/APJCP.2013.14.9.5503
- Reiter PL, Katz ML, Ferketich AK, et al (2009). Measuring cervical cancer risk: development and validation of the care risky sexual behavior index. Cancer Causes and Control, 20, 1865-71. https://doi.org/10.1007/s10552-009-9380-5
- Robyr R, Nazeer S, Vassilakos P, et al (2002). Feasibility of cytology-based cervical cancer screening in rural Cameroon. Acta Cytol, 46, 1110-5. https://doi.org/10.1159/000327116
- Sogukpinar N, Saydam B K, Can H O, et al (2013). Assessment of cervical cancer risk in women between 15 and 49 years of age: case of Izmir. Asian Pac J Cancer Prev, 14, 2119-25. https://doi.org/10.7314/APJCP.2013.14.3.2119
- Solomon D, Ritu N (2004). The Bethesda System for Reporting Cervical Cytology: Definitions, Criteria, and Explanatory Notes. 2nd ed. New York. NY: Springer; 2004.
- Stekler JE, Joann G (2000). Cervical Cancer Screening: Who, When, Why? Academic Search Premier, 13, 124.
- Takei H, Ruiz B, Hicks J (2006). Comparison of conventional Pap smears and a liquid-based thin-layer preparation. Am J Clin Pathol, 125, 855-9. https://doi.org/10.1309/4MM70KG588EM045R
- Tezcan S, Sahincioglu O (2008). Epidemiology and screening programmes in cervical cancer. Turkiye Klinikleri J Gynecol Obst-Special Topics, 1, 1-7.
- Turkish Cervical Cancer and Cervical Cytology Research Group (2009). Prevalence of cervical cytological abnormalities in Turkey. Int J Gynecol Obstet, 106, 206-9. https://doi.org/10.1016/j.ijgo.2009.04.003
- Veena K, Suresh B (2011). Incidence and cytomorphological peculiarities of lower genital tract infections in vault (post hysterectomy) smears versus Pap smears from non-hysterectomy subjects: A retrospective study. JObstetrics Gynecology India, 61, 558-61. https://doi.org/10.1007/s13224-011-0085-9
- Whynes DK, Philips Z, Avis M (2007).Why do women participate in the English cervical cancer screening programme? J Health Econ, 26, 306-25. https://doi.org/10.1016/j.jhealeco.2006.08.007
- World Health Organization (2008). Cervical cancer, human papillomavirus (HPV) and HPV vaccines: Key points for policy-makers and health professionals. WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland
Cited by
- Initial results of population based cervical cancer screening program using HPV testing in one million Turkish women vol.142, pp.9, 2017, https://doi.org/10.1002/ijc.31212